Dova Pharmaceuticals

To build a brand and a site that create awareness and credibility of Dova while clearly communicating the benefits and science behind its current and primary drug candidate, avatrombopag (AVA).

We created a brand, identity and site worthy of a top-flight “clinical-stage” public pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians. Additionally, our success is based on the ability to leverage these creative assets to drive investment in Dova. The ideal execution also best positions Dova for commercial success, first with AVA, and then with pipeline of future drugs to be acquired, developed and brought to market.